Dibasic Piperidines as Mycobacterium Tuberculosis Cell Wall Inhibitors

A chemical series of dibasic piperidines identified as potential inhibitors of Mycobacterium tuberculosis cell wall synthesis. The dataset likely contains results from whole-cell phenotypic growth inhibition screening and mode-of-action studies comparing activity to the front-line drug ethambutol. It was authored by Claire Naylor and shared on figshare in May 2026.

Use Cases

• Identifying novel anti-tuberculosis drug candidates based on whole-cell screening results.
• Comparing compound efficacy against ethambutol-resistant clinical isolates.
• Studying structure-activity relationships within the dibasic piperidine chemical series.
• Investigating alternative drug targets within the mycobacterial cell wall synthesis pathway.

Strengths

• Data is derived from whole-cell phenotypic screening against Mycobacterium tuberculosis, a clinically relevant model.
• Includes comparative analysis against ethambutol-resistant clinical isolates, suggesting relevance for drug resistance research.
• Shared under a CC-BY-NC-4.0 license, permitting non-commercial reuse with attribution.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The dataset is very small (19.5 KB), indicating limited scope.

Provenance

Source

Claire Naylor via figshare.

Collection Method

Likely generated from laboratory experiments involving whole-cell phenotypic growth inhibition screening.

Freshness

Last updated 2026-05-15 02:04:02; freshness should be verified.